Bunsua, Merly L.

HRN: 29-05-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/22/2026
05/29/2026
IVTT
4.5
Q8H
INFECTED WOUND
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines